| Myelodysplastic Syndrome with Genetic Abnormalities studied in …STUDIED_INderived11 of 11show fewer |
|---|
| → studied in | NCT04869683NA · recruiting Biocollection in MyeloDysplastic Syndrome (P-MDS) · condition mapped ALIAS · 11 trials mapped (1 active) | — | — | Myelodysplastic Syndrome with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01869114Phase 2 · completed Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy · condition mapped ALIAS · 11 trials mapped (1 active) | — | — | Myelodysplastic Syndrome with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04701229unknown Haploinsufficiency of the RBM22 and SLU7 Genes in Del(5q) Myelodysplastic Syndromes · condition mapped ALIAS · 11 trials mapped (1 active) | — | — | Myelodysplastic Syndrome with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02666950Phase 2 · completed WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome · condition mapped ALIAS · 11 trials mapped (1 active) | — | — | Myelodysplastic Syndrome with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01273766Phase 2 · completed Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies · condition mapped ALIAS · 11 trials mapped (1 active) | — | — | Myelodysplastic Syndrome with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01789255Phase 2 · completed Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies · condition mapped ALIAS · 11 trials mapped (1 active) | — | — | Myelodysplastic Syndrome with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00445744NA · completed Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome · condition mapped ALIAS · 11 trials mapped (1 active) | — | — | Myelodysplastic Syndrome with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01141725Phase 1/Phase 2 · completed Bendamustine and Idarubicin in Treating Older Patients With Previously Untreated AML or MDS · condition mapped ALIAS · 11 trials mapped (1 active) | — | — | Myelodysplastic Syndrome with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00839982Phase 1/Phase 2 · completed Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS · condition mapped ALIAS · 11 trials mapped (1 active) | — | — | Myelodysplastic Syndrome with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00322101Phase 3 · completed Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia · condition mapped ALIAS · 11 trials mapped (1 active) | — | — | Myelodysplastic Syndrome with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00890747Phase 1 · completed Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy · condition mapped ALIAS · 11 trials mapped (1 active) | — | — | Myelodysplastic Syndrome with del(5q) | 1 | Observed | clinicaltrials | graph → |